Copanlisib T6322
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell
CAS nr:
1032568-63-0
Purity:
98%
Molecular Weight:
480,52
SMILES:
COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12
Formula:
C23H28N8O4
Pathway:
PI3K/Akt/mTOR signaling,Apoptosis
Target:
PI3K,Apoptosis
